Bristol-Myers SquibbvsEli Lilly and Company

BMY and LLY stock compared: price, dividend, valuation and results, from SEC filings.

BMY

Bristol-Myers Squibb Company

$59.56

Value $121B

-2.92%
BMY's page

LLY

Eli Lilly and Company

$1,382.75

Value $1.30T

-2.32%
LLY's page

Bristol-Myers Squibb (BMY) has a market value of $121B and Eli Lilly and Company (LLY) $1.30T. Over the last year, with dividends, BMY moved +32.9% and LLY +36.2%. The P/E is 13.1 for BMY and 47.3 for LLY. Dividend yield: BMY 4.23%, LLY 0.46%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BMY$121B

    LLY$1.30T

    LLY is 11 times BMY

  • Revenue, 12 months

    BMY$50.0B

    LLY$86.5B

    LLY is 1.7 times BMY

  • Net income, 12 months

    BMY$9.2B

    LLY$27.6B

    LLY is 3.0 times BMY

  • Operating margin

    BMY–

    LLY–

  • ROIC

    BMY14.1%

    LLY35.5%

    21.4 points apart

  • P/E

    BMY13.1

    LLY47.3

    LLY is 3.6 times BMY

  • Dividend yield

    BMY4.2%

    LLY0.5%

    3.7 points apart

  • 5-year return

    BMY+23.2%

    LLY+452.8%

    429.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BMY+23.2%

LLY+452.8%

20040060020222023202420252026
Returns by period
PeriodBMYWith dividendsLLYWith dividends
1 year since November 17, 2025+32.9%Price +27.2%+36.2%Price +35.3%
3 years since November 17, 2023+34.9%+10.5% a yearPrice +17.2%+138.4%+33.6% a yearPrice +133.7%
5 years since November 17, 2021+23.2%+4.3% a yearPrice +0.2%+452.8%+40.8% a yearPrice +429.4%
10 years since November 18, 2016+49.9%+4.1% a yearPrice +4.9%+1,997.9%+35.6% a yearPrice +1,703.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BMYBristol-Myers SquibbLLYEli Lilly and Company

Valuation

BMYLLY
Valuation
Price$59.56$1,382.75
Market value$121B$1.30T
Enterprise value (EV)$152B$1.35T
P/E13.147.3
P/E, 5-year median17.849.9
P/B5.232.4
EV/EBIT13.438.8
Free cash flow yield7.7%1.5%

Results and growth

BMYLLY
Results and growth
Revenue, 12 months$50.0B$86.5B
Net income, 12 months$9.2B$27.6B
Free cash flow, 12 months$9.3B$19.7B
Earnings per share, 12 months$4.51$30.81
Revenue growth, year on year-0.2%44.7%
Revenue growth a year, past+2.5%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

BMYLLY
Margins and returns on capital
Gross margin69.2%83.6%
Operating margin––
Net margin18.5%31.9%
ROIC14.1%35.5%
ROE45.0%88.6%

Balance sheet

BMYLLY
Balance sheet
Cash$12.6B$4.9B
Total debt$44.8B$49.5B
Net debt / EBITDA2.01.2
Interest cover6.9×38.9×

Dividends and buybacks

BMYLLY
Dividends and buybacks
Dividend yield4.2%0.5%
Dividend per share, 12 months$2.52$6.34
Dividend growth a year, past+6.2%over 5 years+15.2%over 5 years
Buyback yield–0.3%
Shareholder yield4.2%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BMY or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Bristol-Myers Squibb or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.30T) is about 10.8 times Bristol-Myers Squibb ($121B), at today's prices.

How did BMY and LLY stock do over the last 10 years?

Since November 18, 2016, BMY's price moved +4.9% and LLY's +1,703.5%. With dividends: BMY +49.9% (+4.1% a year), LLY +1,997.9% (+35.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, BMY or LLY?

The dividend yield at today's price is 4.23% for Bristol-Myers Squibb and 0.46% for Eli Lilly and Company. Over the last twelve months they paid $2.52 and $6.34 per share.

What is the P/E of BMY and LLY?

At today's price, the P/E is 13.1 for BMY and 47.3 for LLY. The median of the last five years was 17.8 and 49.9, which shows where each stands against its own past.

Which has the higher profit margins, Bristol-Myers Squibb or Eli Lilly and Company?

Over the last twelve months, the net margin was 18.5% for Bristol-Myers Squibb and 31.9% for Eli Lilly and Company, and the operating margin – and –. Revenue was $50.0B and $86.5B.

Which is the better investment, Bristol-Myers Squibb or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.